OPRX OptimizeRx Corp: Business Value to Revenue

Public company logo of OptimizeRx (OPRX)

The transition to electronic document management has reduced paper usage, triggering an increase in the EV/Sales valuation multiple for OptimizeRx Corporation (OPRX), which currently stands at 1309.66. This price action reflects the successful integration of AI into cloud services for healthcare providers and the reliable digital transmission of prescriptions that eliminates errors in the patient care chain, fundamentally strengthening the position of OptimizeRx Corporation (OPRX) within the health-IT sector.

OPRX: OptimizeRx Inc. Company Value to Revenue 11/23/2025 - 11/20/2026

OPRX (optimizerx.com): analytical breakdowns and indicator data

- price and consensus price forecast:
Initial company analysis:optimizerx.com OPRX
Manufactured product of OptimizeRx Corporation

For OptimizeRx Corporation (OPRX), which is actively integrating AI into predictive marketing, this indicator serves as a gauge of market confidence in revenue scaling rates. The metric combines market capitalization and net debt, comparing the total enterprise value to sales volume. Analyzing the change in enterprise value to revenue allows for the identification of asset overheating or an undervaluation of its technological potential. The trend line reflects the balance between expectations for AI innovations and accumulated risks. This is a key tool for managing the entry point into a growing R&D cycle.

Competitor analysis

Enterprise Value-to-Revenue Multiple veeva.com|DOCS (Doximity) - Company Value to Revenue|HQY - Total Company Value-to-Revenue Ratio|Enterprise Value-to-Revenue Ratio Waystar Inc.|CRVL: Business Value to Revenue|Enterprise Value-to-Revenue Ratio Privia Health Group (PRVA)|EV/Sales Multiple huronconsultinggroup.com (HURN)|Certara Inc - Company Value to Revenue|OMCL - Company Value to Revenue|GDRX - Enterprise Value-to-Revenue Ratio|Total Company Value-to-Revenue Ratio Schrodinger Corp SDGR|PHR: EV/Sales Multiple|OMDA - Total Company Value-to-Revenue Ratio|EVH (Evolent Health Inc) - EV/Sales Multiple|Company Value to Revenue Ratio HSTM (HealthStream)|EV/Sales Multiple DH|CCSI (Consensus Corp) - Business Value to Revenue|agilon health Inc - Company Value to Revenue|absci.com - Enterprise Value-to-Revenue Ratio|SY - Enterprise Value-to-Revenue Ratio|Business Value to Revenue NRC (National Research)|USA Mobility (SPOK) - Enterprise Value-to-Revenue Ratio|TBRG - Total Company Value-to-Revenue Ratio|Company Value to Revenue SLP|Enterprise Value-to-Revenue Multiple sophiagenetics.com SOPH|EV/Sales Multiple HCAT|CCLD (CareCloud Inc.) - Business Value to Revenue|Enterprise Value-to-Revenue Ratio Research Solutions Inc. RSSS|DLHC - Company Value to Revenue|ONMD - Enterprise Value-to-Revenue Ratio|Total Company Value-to-Revenue Ratio Scienture Holdings Inc SCNX|HCTI: EV/Sales Multiple|Company Value to Revenue Ratio ISPC|BFRG (Bullfrog AI) - EV/Sales Multiple|Company Value to Revenue SCWorx Inc (WORX)|EV/Sales Multiple MSPR|ICCT - Enterprise Value-to-Revenue Multiple|EV/Sales Multiple MEDS (TRxADE Health Corp)|Enterprise Value-to-Sales Ratio Orgenesis|R1 RCM - EV/Sales Multiple|Business Value to Revenue SHCR (Sharecare, Inc)|STRM (Streamline Health Solutions Inc.) - Company Value to Revenue|Enterprise Value-to-Revenue Multiple syrahealth.com (SYRA)|Company Value to Revenue AMEH|MODN: Business Value to Revenue|Company Value to Revenue NXGN (NextGen Healthcare)